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Essential Roles for Mycobacterium tuberculosis Rel beyond the
Production of (p)ppGpp
Leslie A. Weiss, Christina L. Stallings
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA
InMycobacterium tuberculosis, the stringent response to amino acid starvation is mediated by theM. tuberculosis Rel (RelMtb)
enzyme, which transfers a pyrophosphate from ATP to GDP or GTP to synthesize ppGpp and pppGpp, respectively. (p)ppGpp
then influences numerous metabolic processes. RelMtb also encodes a second, distinct catalytic domain that hydrolyzes (p)ppGpp
into pyrophosphate and GDP or GTP. RelMtb is required for chronicM. tuberculosis infection in mice; however, it is unknown
which catalytic activity of RelMtb mediates pathogenesis and whether (p)ppGpp itself is necessary. In order to individually inves-
tigate the roles of (p)ppGpp synthesis and hydrolysis duringM. tuberculosis pathogenesis, we generated RelMtb point mutants
that were either synthetase dead (RelMtb
H344Y) or hydrolase dead (RelMtb
H80A).M. tuberculosis strains expressing the synthetase-
dead RelMtb
H344Y mutant did not persist in mice, demonstrating that the RelMtb (p)ppGpp synthetase activity is required for
maintaining bacterial titers during chronic infection. Deletion of a second predicted (p)ppGpp synthetase had no effect on
pathogenesis, demonstrating that RelMtb was the major contributor to (p)ppGpp production during infection. Interestingly, ex-
pression of an allele encoding the hydrolase-dead RelMtb mutant, RelMtb
H80A, that is incapable of hydrolyzing (p)ppGpp but still
able to synthesize (p)ppGpp decreased the growth rate ofM. tuberculosis and changed the colony morphology of the bacteria. In
addition, RelMtb
H80A expression during acute or chronicM. tuberculosis infection in mice was lethal to the infecting bacteria.
These findings highlight a distinct role for RelMtb-mediated (p)ppGpp hydrolysis that is essential forM. tuberculosis
pathogenesis.
At least 30% of the world’s population is infected with latentMycobacterium tuberculosis, which will reactivate in some in-
dividuals and cause an estimated 1.4 million deaths a year (1).
Significant obstacles in controlling the epidemic result from the
chronic nature of M. tuberculosis infection, which necessitates
prolonged treatment and generates a large reservoir of latently
infected people. This health crisis is exacerbated by the alarming
emergence of drug-resistant strains. The inadequacies of present
tuberculosis therapies demand the discovery of new agents to treat
M. tuberculosis infection, which requires insight into the pathways
used by the pathogen to survive in the host. During infection, the
host restrains mycobacteria from proliferating by imposing an
arsenal of defenses, including oxidative stress, hypoxia, acid stress,
genotoxic stress, cell surface stress, and starvation (reviewed in
reference 2). Despite this onslaught of attacks, M. tuberculosis is
able to persist for the lifetime of the host, indicating that this
pathogen has substantial molecular mechanisms to resist host-
inflicted damage.
One way bacteria resist stress is via the stringent response. The
stringent response is a conserved global stress response in bacteria
that involves the production of the hyperphosphorylated guanine
nucleotides ppGpp and pppGpp [collectively called (p)ppGpp].
(p)ppGpp metabolism is controlled by Rel/SpoT homolog pro-
teins (RSHs), named for their sequence similarity to RelA and
SpoT enzymes in Escherichia coli (3). The activity of RelA ho-
mologs is best characterized during amino acid starvation when
an uncharged tRNA enters the A site of the ribosome and stimu-
lates RelA-mediated (p)ppGpp production (4). (p)ppGpp then
regulates a number of cellular processes, including transcription,
replication, cell surface morphology, and nucleotide levels (re-
viewed in references 5 and 6).
In M. tuberculosis, the stringent response is initiated by the M.
tuberculosis Rel (RelMtb) enzyme, which transfers the 5=-,-py-
rophosphate from ATP to the 3=-OH of GDP or GTP to synthesize
ppGpp and pppGpp, respectively (7). The (p)ppGpp synthetase
domain is in the middle of the RelMtb protein, and a mutation of a
conserved histidine (H344) or glycine (G241) residue in this do-
main abolishes synthetase activity (8, 9). The C terminus of RelMtb
is not required for catalytic activity but is necessary for association
with the RelMtb activating complex, which consists of ribosomes,
mRNA, and tRNAs and regulates (p)ppGpp synthesis (10, 11).
RelMtb also hydrolyzes (p)ppGpp into diphosphate pyrophos-
phate (PPi) and GDP or GTP via an N-terminal catalytic HD su-
perfamily domain that is distinct from the (p)ppGpp synthetase
domain (9). HD superfamily members are phosphohydrolases
with conserved histidine and aspartate residues that are involved
in the coordination of divalent cations, which is essential for their
activity (12). Alanine substitution of the conserved histidine
(H80) or aspartate (D81) residue in RelMtb abolishes hydrolase
activity in vitro without affecting (p)ppGpp synthesis (9). The
crystal structure of the RelMtb homolog in Streptococcus dysgalac-
tiae subsp. equisimilis, RelSeq, indicates that at any given time only
one enzymatic function is active, thereby preventing simultane-
ous synthesis and hydrolysis of (p)ppGpp (13).
M. tuberculosis mutants deleted for the entire relMtb gene
(relMtb) are compromised for long-term survival in culture (7)
and are unable to persist in mouse models of infection (14, 15). In
Mycobacterium smegmatis, deletion of relMsm causes changes in
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cellular and colony morphology, decreased long-term survival,
and increased sensitivity to nutrient starvation and hypoxia (16).
However, it is still unclear which catalytic activities of RelMtb con-
tribute to these diverse phenotypes and what role (p)ppGpp has in
these processes. In addition to RelMtb, M. tuberculosis also encodes
a homolog to a group of RSHs called small alarmone synthetases
(SAS), which encode the catalytic domain to produce (p)ppGpp
but not the hydrolase domain (3). The role of the M. tuberculosis
SAS, Rv1366, in maintaining (p)ppGpp levels, responding to
stress, and virulence has yet to be investigated. In many other
bacteria, SAS activity is toxic in the absence of a functional
(p)ppGpp hydrolase (17–21). If this were the case in M. tubercu-
losis, Rv1366-mediated (p)ppGpp synthesis in the relMtb strain
could be the cause for attenuation of this strain. We have ad-
dressed these questions regarding the roles of (p)ppGpp metabo-
lism by studying strains of M. tuberculosis that express alleles of
RelMtb that are defective in individual catalytic activities and
strains deficient in the rv1366 gene.
MATERIALS AND METHODS
M. tuberculosis strains and media. All M. tuberculosis strains were de-
rived from Erdman and were grown planktonically at 37°C in 7H9 (broth)
or 7H10 (agar) (Difco) medium supplemented with 10% oleic acid-albu-
min-dextrose-catalase (OADC), 0.5% glycerol, and 0.05% Tween 80
(broth). Biofilm cultures were grown in 24-well dishes at 37°C by inocu-
lating 1.5 ml of Sauton’s medium with 150 l of saturated planktonic
culture. The 24-well dish was placed in a tightly sealed Tupperware dish
for 3 weeks, at which point the Tupperware was opened and incubated for
another week before photographing. This is similar to previously de-
scribed conditions used to form M. tuberculosis biofilms (22).
TherelMtb strain was made by infecting M. tuberculosis Erdman with
a specialized transducing phage (phAE87) containing homology to M.
tuberculosis nucleotides 2907267 to 2907826 and 2910191 to 2910844,
which replaced all but the first two codons and the stop codon of the
endogenous relMtb gene with a hygromycin resistance cassette. The
rv1366 strain was made by infecting wild-type (WT) M. tuberculosis
Erdman with phAE87 containing homology toM. tuberculosisnucleotides
1537706 to 1538406 and 1539203 to 1539884, which replaced all but the
first 6 codons and the last 2 codons of the endogenous rv1366 gene with a
hygromycin resistance cassette flanked by two loxP sites. The deletion of
rv1366 in this strain was confirmed by EcoRI digestion of genomic DNA
and Southern blot analysis using a radiolabeled fragment containing M.
tuberculosis nucleotides 1537706 to 1538406 as the probe. The hygromy-
cin resistance cassette was cured from therv1366 strain by transforming
the strain with an unstable episomal plasmid (pmsg381) that expresses the
Cre recombinase. Loss of the hygromycin resistance cassette was con-
firmed by both PCR and plating in the presence or absence of hygromycin.
The relMtb gene was deleted from the rv1366 strain to make the relMtb
rv1366 strain by infecting the rv1366 strain, which had been cured of
the hygromycin resistance cassette, with the phAE87 phage that replaces
the endogenous relMtb gene with a hygromycin resistance cassette. The
deletion of the relMtb gene in this strain was confirmed by Southern blot
analysis of SmaI-digested genomic DNA using a radiolabeled fragment
containing M. tuberculosis nucleotides 2910191 to 2910844 as a probe.





rv1366 allele from the attB site of the gene deletion strains, the relMtb,
rv1366, or relMtb rv1366 strain was transformed with a pMSG430
plasmid that integrates into the attB site of the genome, confers kanamy-
cin resistance, and expresses the respective allele from a constitutive
pmyc1tetO promoter. Control strains were made by transforming each
deletion mutant with an empty pMSG430 vector. The relMtb and rv1366
genes from each transformant were sequenced to confirm the presence of
the correct sequence. There is only a single copy each of the relMtb and
rv1366 genes in all strains of mycobacteria used in this paper.
To achieve conditional expression of relMtb
H80A, therelMtb strain was
cotransformed with pMSG430-relMtb
H80A and pTES-2MOX (kindly pro-
vided by Dirk Schnappinger and Sabine Ehrt, Cornell University, NY),
which confers streptomycin resistance and expresses the WT tetracycline
repressor (TetR). This generated the Tet-RelMtb
H80A strain, wherein the
WT TetR allows for induced expression of the relMtb
H80A allele in the
presence of tetracycline (Tet) analogs. A control strain was constructed by
cotransforming WT M. tuberculosis Erdman with empty pMSG430 and
pTES-2MOX.
M. smegmatis strains and media. All M. smegmatis strains were iso-
genic to strain mc2155 and were grown at 37°C in LB (broth and agar) or
7H10 (agar) supplemented with 0.5% dextrose, 0.5% glycerol, and 0.05%
Tween 80 (broth). TherelMsm strain was made by infecting mc
2155 with
phAE87 containing homology to mc2155 nucleotides 3027905 to 3028545
and 3030884 to 3031534, which deleted all but the first 4 codons and the
last 14 codons of the relMsm gene. The M. smegmatis Tet-RelMtb
H80A strain
was made as described forM. tuberculosis. TheM. smegmatis control strain
was made by cotransforming the relMsm strain with pMSG430-relMtb
WT
and pTES-2MOX.
Antibiotics. Twenty g/ml kanamycin, 50 g/ml hygromycin, 20
g/ml streptomycin, and 50 ng/ml of anhydrotetracycline (ATc) were
used for both mycobacterial species.
Mouse infections. Before infection, exponentially replicating M. tu-
berculosis bacteria were washed in phosphate-buffered saline (PBS) plus
0.05% Tween 80 and sonicated to disperse clumps. Eight- to 9-week-old
female C57BL/6 mice (Jackson Laboratory) were exposed to 8 107 CFU
of the appropriate strain in an inhalation exposure system (Glas-Col),
which delivers100 bacteria to the lung per animal. Bacterial burden was
determined by plating serial dilutions of lung and spleen homogenates
onto 7H10 agar plates in the absence or presence of kanamycin and strep-
tomycin. Plates were incubated at 37°C in 5% CO2 for 3 weeks prior to
counting colonies. When indicated, the standard diet was replaced with
doxycycline-containing mouse chow (2,000 ppm; Research Diets). All
procedures involving animals were conducted by following the National
Institutes of Health guidelines for housing and care of laboratory animals
and were performed in accordance with institutional regulations after
protocol review and approval by the Institutional Animal Care and Use
Committee of The Washington University in St. Louis School of Medicine
(protocol 20100190; Analysis of Mycobacterial Pathogenesis). Washing-
ton University is registered as a research facility with the U.S. Department
of Agriculture and is fully accredited by the American Association of Ac-
creditation of Laboratory Animal Care. The Animal Welfare Assurance is
on file with OPRR-NIH. All animals used in these experiments were sub-
jected to no or minimal discomfort. All mice were euthanized by CO2
asphyxiation, which is approved by the Panel on Euthanasia of the Amer-
ican Veterinary Association.
qRT-PCR. RNA was extracted from exponentially growing mycobac-
teria using TRIzol (Invitrogen), cDNA was prepared using Superscript III
(Invitrogen), and quantitative reverse transcription-PCR (qRT-PCR) was
performed using the Bio-Rad Sso Advanced SYBR green kit. Levels of
relMtb and relMsm transcript were normalized to sigA transcript levels as
previously described (23).
Assaying nucleotide and metabolite levels using LC-MS/MS. M.
smegmatis Tet-RelMtb
H80A and control strains were grown to exponential
phase and treated with 50 ng/ml ATc for 6 h, and 5.9  109 CFU per
sample was collected and washed in PBS. ATP, GTP, ppGpp, and pppGpp
were assayed using a liquid chromatography-tandem mass spectrometry
(LC-MS/MS) method. For the nucleotide extraction, 10 l of 0.1 mM
internal standard Br-ATP was spiked in each sample. Six hundred l of
cold 50% ethanol was added to each sample, and samples were homoge-
nized with TissueLyser II for 5 min at a frequency of 20 Hz/s. After cen-
trifugation at 16,000  g for 5 min at 4°C, the supernatants were trans-
ferred to new tubes and the pellets were reextracted as previously
described. The second supernatant was combined with the first one and
dried down. The pellets were dissolved in water for LC-MS/MS analysis.
Weiss and Stallings
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The LC-MS/MS system used is composed of a Shimadzu LC system
with two Shimadzu solvent delivery pumps (model LC10AD), a Shi-
madzu integrated controller (SCL10Avp), a Valco two-position diverter
valve, and a LEAP CTC PAL autosampler with a 50-l sample loop. This
LC system is interfaced with an AB Sciex 4000 QTRAP mass spectrometer
equipped with a TurboIonSpray (TIS) electrospray ion source. Source
parameters were set as the following: curtain gas, 10 arbitrary units (AU);
source gas 1, 50 AU; source gas 2, 50 AU; collision activated dissociation,
high; interface heater, on; temperature, 650°C; ionspray voltage,4,500.
Both quadruples (Q1 and Q3) were set to unit resolution. Analyst software
(version 1.4.2) was used to control sample acquisition and data analysis.
The 4000 QTRAP mass spectrometer was tuned and calibrated according
to the manufacturer’s recommendations. Each compound was detected
using 3 multiple reaction monitoring (MRM) transitions that were previ-
ously optimized using standards described in Table 1, with the exception
of pppGpp, for which no commercial standard is available. Only 2 MRM
transitions for pppGpp were used based on the ppGpp standard.
For LC separation, a Synergi 2.5-U Hydro-RP 100A column (100 by 2
mm; Phenomenex) was used at a flow rate of 0.11 ml/min. The gradient
started at 100% solvent A (10 mM tributylamine in 5% methanol, pH 4.8),
was held for 2 min, and then moved to 20% solvent B (100% methanol) in
2 min. The gradient then increased to 50% solvent B in 33 min. It was
finally ramped up to 90% solvent B in 1 min and then ramped back to
initial conditions (100% solvent A) in 1 min and reequilibrated for an
additional 7 min. For quantification, a series of standard samples contain-
ing different concentrations of compounds was prepared. Calibration
curves for all of the compounds were achieved by integration of the peak
area under the curve of the standards and then normalized to the internal
standard Br-ATP.
RESULTS
RelMtb-mediated (p)ppGpp synthesis is required forWTrates of
growthon solidmedia and formationof biofilms.Deletion ofM.
tuberculosis relMtb results in slightly slower growth, compromised
long-term survival in cultures (7), and an inability to persist in
mouse models of infection (14, 15). relMtb encodes two different
enzymatic activities, (p)ppGpp synthesis and hydrolysis, and it is
unknown if the phenotypes of the relMtb strain result exclusively
from the loss of (p)ppGpp production. A RelMtb
H344Y point mu-
tant is unable to synthesize (p)ppGpp but retains hydrolase activ-
ity in vitro (9). To determine whether RelMtb-mediated (p)ppGpp
synthesis is specifically important for mycobacteria, we con-
structed M. tuberculosis strains deleted for the endogenous relMtb
gene and constitutively expressing either the relMtb
WT allele or the
relMtb
H344Y synthetase-dead mutant from the attB site of the ge-
nome. As previously reported, the M. tuberculosis relMtb mutant
grew more slowly than a strain complemented with the relMtb
WT
allele, which is particularly evident on 7H10 solid media (Fig. 1A)
(7). Expression of the RelMtb
H344Y mutant did not fully comple-
ment this growth defect, demonstrating that (p)ppGpp synthesis
by RelMtb is necessary for optimal growth on solid media. A lower
growth rate was defined by smaller colony size on 7H10 plates, as
illustrated in Fig. 1A at the 103 and 104 dilutions. In addition to
the slow growth on solid media, we also observed that loss of
RelMtb-mediated (p)ppGpp synthetase activity resulted in delayed
formation of biofilms and pellicles in static liquid cultures (Fig.
1B). This illustrates another in vitro condition that requires
RelMtb-mediated (p)ppGpp synthesis. Biofilms may serve as a
model for persister cell formation, in that they harbor a larger
number of drug-tolerant cells than planktonic M. tuberculosis cul-
tures (22). Thus, this defect in biofilm formation by the relMtb
mutant may be due to the interference of the same pathways nec-
essary to persist in the mouse infection model.
(p)ppGpp synthesis by RelMtb is required for chronic infec-
tion in mice.M. tuberculosis infection in mice begins with an ini-
tial phase of unrestricted bacterial growth termed acute infection.
The onset of adaptive immunity stops the bacterial titers from
increasing at 3 to 4 weeks postinfection, but bacteria are still able
to persist for the lifetime of the mouse. M. tuberculosis relMtb
aerosol infection of mice results in normal initial bacterial growth
but impaired chronic infection, resulting in less severe gross pa-
thology of the disease (Fig. 2) (14). To determine whether RelMtb-
mediated (p)ppGpp synthesis was specifically required for
chronic infection, we infected C57BL/6 mice with M. tuberculosis
relMtb expressing relMtb
WT, relMtb
H344Y, or no relMtb allele from
the attB site. M. tuberculosis strains expressing the RelMtb
H344Y
mutant phenocopied the null mutant by not persisting in the mu-
rine lungs and spleens and causing less tissue pathology than con-
trol strains, demonstrating that RelMtb (p)ppGpp synthetase ac-
tivity is required for chronic M. tuberculosis infection (Fig. 2).
Rv1366 activity does not contribute to phenotypes of a
relMtb mutant and is dispensable for pathogenesis in the
mouse model of infection. The SAS homolog Rv1366 is a second
predicted (p)ppGpp synthetase in M. tuberculosis and could con-
TABLE 1 Mass spectrometry of nucleotide standardsa
Q1 MS Q3 MS Time (ms) Name DP (V) CE (V)
506.2 408.0 50 ATP1 70 30
506.2 158.8 50 ATP2 70 35
506.2 78.8 50 ATP3 70 80
522.2 423.9 50 GTP1 70 30
522.2 158.8 50 GTP2 70 40
522.2 78.8 50 GTP3 70 80
602.2 504.0 50 ppGpp1 70 35
602.2 423.9 50 ppGpp2 70 45
602.2 158.8 50 ppGpp3 70 60
682.2 584.0 50 pppGpp1 70 35
682.2 504.0 50 pppGpp2 70 45
586.0 273.0 50 Br-ATP1 55 60
586.0 159.0 50 Br-ATP2 55 50
586.0 79.0 50 Br-ATP3 55 95















FIG 1 RelMtb-mediated (p)ppGpp synthesis is necessary for optimal M. tuber-
culosis growth and biofilm formation in vitro. M. tuberculosis relMtb strains
containing a vector that constitutively expresses RelMtb
WT (WT) or
RelMtb
H344Y (H344Y) or containing an empty vector () integrated at the attB
site in the genome were normalized to the same OD	600 and either diluted and
plated on 7H10 plates (A) or grown in Sauton’s medium in static, biofilm-
forming conditions in a 24-well dish (B). (A) 7H10 plates were incubated for 3
weeks at 37°C. (B) Biofilms were incubated for 4 weeks at 37°C. The parent
strain used is labeled above each photo, and the protein expressed from the
attB site is labeled below the photo.
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tribute to (p)ppGpp metabolism; however, it has yet to be char-
acterized. To investigate the function of Rv1366, we constructed
an M. tuberculosis strain deleted for the predicted (p)ppGpp syn-
thetase rv1366 (rv1366 strain) and anM. tuberculosis double mu-
tant of relMtb and rv1366 (relMtb rv1366 strain), which were
both confirmed by Southern blot analysis (Fig. 3A and B), and
monitored their growth rate and ability to form biofilms. The
rv1366 mutant did not have a growth defect compared to con-
trols on either solid media or under biofilm conditions (Fig. 3C
and D). Additionally, the relMtb rv1366 double mutant pheno-
copied the relMtb single mutant on both solid media (data not
shown) and under biofilm conditions (Fig. 3D). Expression of
RelMtb
WT was also able to fully complement the growth and bio-
film phenotypes in the relMtb rv1366 double mutant (Fig. 3C
and D). These data demonstrate that Rv1366 does not provide a
function necessary for growth in nutrient-rich media or under
biofilm conditions regardless of the presence of RelMtb-mediated
(p)ppGpp synthesis. We then examined whether Rv1366 was nec-
essary during M. tuberculosis infection of mice by infecting
C57BL/6 mice with the rv1366 mutant and the relMtb rv1366
double mutant. The rv1366 single mutant was not attenuated
during infection in either the lung or the spleen, and the relMtb
rv1366 double mutant phenocopied therelMtb mutant and was
fully complemented by expression of only RelMtb
WT (Fig. 4).
These data show that Rv1366 is not necessary for M. tuberculosis
growth or survival in vitro or in vivo in the models tested.
In Bacillus subtilis, the phenotypes of the relA strain are at-
tributed in part to the absence of (p)ppGpp hydrolase activity in
the presence of two SAS homologs, such that suppressors of the B.
subtilisrelAmutant have inactivating mutations in the SAS genes
(17). Therefore, we wanted to confirm that the M. tuberculosis






































































































FIG 2 RelMtb-mediated (p)ppGpp synthesis is necessary for chronic M. tuber-
culosis infection in mice. C57BL/6 mice were infected with M. tuberculosis
relMtb strains containing a vector that constitutively expresses RelMtb
WT (WT;
open circles) or RelMtb
H344Y (H344Y; open triangles) or containing an empty
vector (; open squares) integrated at the attB site in the genome. Shown are
bacterial titers from lungs (A and B) and spleens (C and D) at various time
points. Each time point is the means
 standard errors of the means (SEM) of
data from 3 to 4 mice per strain. (B and D) Significance of differences com-
pared to the RelMtb
WT-expressing strain at 9 and 13 weeks postinfection was
determined by calculating P values by Student’s t tests; one asterisk indicates
significance with a P value of0.05, and three asterisks indicates a significance
with a P value of0.005. (E) Gross pathology of representative left lungs from
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FIG 3 Rv1366 is not necessary forM. tuberculosis growth or biofilm formation
in vitro. (A) Southern blot analysis of WT M. tuberculosis Erdman (lane 1) and
the rv1366 strain (lanes 2 to 4) using EcoRI-digested genomic DNA and a
probe that spans nucleotides 1537706 to 1538406 of the M. tuberculosis ge-
nome. EcoRI digestion of WT M. tuberculosis yields a band at 5,083 bp. EcoRI
digestion of rv1366 results in a 2,226-bp band due to the replacement of the
rv1366 gene with a hygromycin resistance cassette. (B) Southern blot analysis
of WT M. tuberculosis Erdman (lane 1) and therelMtbrv1366 strain (lanes 2
to 6) using SmaI-digested genomic DNA and a probe that spans nucleotides
2910191 to 2910844 of the M. tuberculosis genome. SmaI digestion of WT M.
tuberculosis yields a band at 2,257 bp. SmaI digestion of the relMtb rv1366
strain results in a 4,769-bp band due to the replacement of the relMtb gene with
a hygromycin resistance cassette. (C and D) M. tuberculosis relMtb, rv1366,
and relMtbrv1366 strains containing a vector that constitutively expresses
RelMtb
WT or Rv1366 or containing an empty vector () integrated at the attB
site in the genome were normalized to the same OD	600 and either diluted and
plated on 7H10 plates (C) or grown in Sauton’s media in static, biofilm-form-
ing conditions in a 24-well dish (D). (C) 7H10 plates were incubated for 3
weeks at 37°C. (D) Biofilms were incubated for 4 weeks at 37°C. The parent
strain used is labeled above each photo, and the protein expressed from the
attB site is labeled below the photo.
Weiss and Stallings
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along with 159 nucleotides upstream and 182 nucleotides down-
stream of the rv1366 gene in WT M. tuberculosis and relMtb
strains. The nucleotide sequences were identical between strains
and were the same as the sequence deposited in NCBI for the M.
tuberculosis H37Rv strain. Therefore, the role of Rv1366 in M.
tuberculosis remains unknown, but its function is not redundant
with (p)ppGpp production by RelMtb under the conditions exam-
ined.
RelMtb hydrolase activity is critical for mycobacterial physi-
ologywhen (p)ppGpp synthesis is intact. In addition to (p)ppGpp
synthesis, RelMtb is the only known enzyme in M. tuberculosis that is
capable of hydrolyzing (p)ppGpp for turnover and renewal of GTP
and GDP by removal of pyrophosphate. In order to investigate the
roles of the RelMtb hydrolase activity during growth and survival, we
attempted to generate strains of M. tuberculosis expressing a single
copy of RelMtb that was hydrolase dead but retained (p)ppGpp syn-
thetase activity (RelMtb
H80A) or was inactive for both synthesis and
hydrolysis (RelMtb
H80A-H344Y). Although we were able to obtain the
M. tuberculosis RelMtb
H80A-H344Y-expressing strain, we did not re-
cover clones expressing the relMtb
H80A allele. This suggested that the
retention of the RelMtb (p)ppGpp synthetase activity is toxic in the
absence of a functional hydrolase. To investigate this further, we
used a tetracycline-inducible expression system (24) and engineered
an M. tuberculosis relMtb strain to induce expression of the
relMtb
H80A allele from a cassette at the attB site in the presence of
tetracycline analogs, such as anhydrotetracycline (ATc), due to the
expression of a tetracycline repressor (TetR) from an episomal plas-
mid. We named this strain Tet-RelMtb
H80A. We also constructed a
control strain by inserting an empty vector into theattB site of WTM.
tuberculosis and transforming this strain with the same TetR-express-
ing plasmid as that in Tet-RelMtb
H80A. relMtb expression from its en-
dogenous locus in the control strain is not affected by ATc (Fig. 5A).
Induction of relMtb
H80A transcription in the presence of ATc in the
Tet-RelMtb
H80A strain was confirmed by quantitative real-time PCR
(qRT-PCR) (Fig. 5A).
We plated the M. tuberculosis control and Tet-RelMtb
H80A
strains onto 7H10 agar in the absence or presence of ATc and
found that although the strains had equivalent survival rates un-
der both conditions, the Tet-RelMtb
H80A strain exhibited smaller,
rounder, and smoother colonies than control bacteria in the pres-
ence of ATc (Fig. 5B). This demonstrates that inducing expression
of RelMtb
H80A, which will synthesize (p)ppGpp but will not hydro-
lyze (p)ppGpp, has an impact onM. tuberculosis physiology. Thus,
(p)ppGpp turnover is required to maintain normal colony mor-
phology. There was a mild effect on colony morphology in the
Tet-RelMtb
H80A strain in the absence of ATc (Fig. 5B), suggesting
that even low levels of relMtb
H80A expression in the absence of
inducer due to the inherent leakiness of the TetR system was
enough to affect bacterial physiology. This low level of relMtb
H80A
transcription in the Tet-RelMtb
H80A strain in the absence of ATc
was detectable by qRT-PCR and was close to 100-fold lower than
in induced conditions (Fig. 5A).
We also engineered M. smegmatis relMsm strains to induce




H80A) in the presence of ATc. Similar
to the results fromM. tuberculosis experiments, when we platedM.
smegmatis Tet-RelMtb
WT and Tet-RelMtb
H80A on 7H10 agar in the
presence of ATc, the Tet-RelMtb
H80A strain exhibited smaller,
smoother colonies than the Tet-RelMtb
WT strain (Fig. 5C). This
demonstrated that the role of (p)ppGpp turnover in colony mor-
phology is conserved in M. tuberculosis and M. smegmatis. Inter-
estingly, when we plated the M. smegmatis Tet-RelMtb
WT and Tet-
RelMtb
H80A strains on LB agar in the absence or presence of ATc,
the induced expression of the relMtb
H80A mutant allele inhibited
growth (Fig. 5D and E) and all of the Tet-RelMtb
H80A colonies that
grew were no longer responsive to the presence of ATc, as deter-
mined by plating and qRT-PCR. Therefore, in order to grow on
nutrient-rich LB media, the M. smegmatis Tet-RelMtb
H80A strain
must mutate the Tet-inducible system and permanently repress
the expression of relMtb
H80A to survive. This proved that inhibition
of the RelMtb (p)ppGpp hydrolase activity in the presence of a
functional (p)ppGpp synthetase is toxic to M. smegmatis in nutri-
ent-rich LB media and links nutrient availability with the impor-
tance of (p)ppGpp turnover. (p)ppGpp production has been as-
sociated with colony morphology in mycobacteria (16, 25), but
this is the first time in mycobacteria that the hydrolysis of
(p)ppGpp has been shown to be required for maintenance of WT
colony morphology and growth in nutrient-rich conditions.
(p)ppGpp levels were measured in the M. smegmatis Tet-
RelMtb
WT and Tet-RelMtb


































































































































































































FIG 4 Rv1366 is not necessary for M. tuberculosis pathogenesis in mice. C57BL/6
mice were infected with the WTM. tuberculosisErdman strain (open squares), the
rv1366 strain (open circles), the relMtb rv1366 strain containing an empty
vector integrated at the attB site in the genome (relMtbrv1366; open triangles),
or the relMtb rv1366 strain containing a vector that constitutively expresses
RelMtb
WT from the attB site in the genome (relMtb rv1366  relMtb; closed
circles). Shown are bacterial titers from lungs (A and B) and spleens (C and D) at
various time points. Each time point is the means
 SEM of data from 3 to 4 mice
per strain. (B and D) Significance of differences compared to therelMtbrv1366
strain at 9 and 13 weeks postinfection was determined by calculating P values by
Student’s t tests; one asterisk indicates significance with a P value of 0.05, and
three asterisks indicates significance with a P value of0.005.
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FIG 5 RelMtb-mediated (p)ppGpp hydrolysis is required for growth in vitro and maintenance of ATP and GTP levels when (p)ppGpp is being produced. (A and
B) An M. tuberculosisrelMtb strain containing an episomal vector expressing the WT TetR that induces expression of relMtb
H80A from a cassette integrated at the
attB site in the genome in the presence of ATc (Tet-RelMtb
H80A strain, designated H80A here) and a WT M. tuberculosis strain containing an empty vector in the
attB site and transformed with the same TetR-expressing plasmid (control strain). (A) Transcript levels in exponential-growth-phase cultures in liquid 7H9
media. relMtb
H80A transcripts from the cassette at the attB site were detected in the Tet-RelMtb
H80A strain, and transcripts from the endogenous relMtb gene were
detected in the control strain. The first comparison shows the ratio of transcript levels in the presence compared to the absence of ATc in each strain
(ATc/ATc), and it illustrates the induction of relMtb
H80A in the Tet-RelMtb
H80A strain when exposed to ATc and the unresponsiveness of the relMtb gene to ATc
in the control strain. The second comparison shows the ratio of transcript levels in the Tet-RelMtb
H80A strain compared to the control strain (H80A/control)
under each condition to illustrate the low level of transcription of relMtb
H80A in the absence of ATc compared to that of induced cultures. (B) M. tuberculosis
Tet-RelMtb
H80A and control strains were diluted and plated on 7H10 plates in the absence or presence of ATc. (C to G) M. smegmatis relMsm strains containing
an episomal vector expressing the WT TetR that turns on expression of relMtb
WT (Tet-RelMtb
WT strain; designated the control) or relMtb
H80A (Tet-RelMtb
H80A
strain; designated H80A here) from cassettes integrated at the attB site in the genome in the presence of ATc. (C and D) M. smegmatis strains were diluted and
plated on 7H10 (C) and LB (D) plates in the absence or presence of ATc. (E) Graphic representation of the number ofM. smegmatisCFU that grew in the presence
compared to the absence of ATc when grown on LB, where all Tet-RelMtb
H80A strain bacteria that grew in the presence of ATc on LB were suppressors and were
no longer responsive to ATc treatment. Data are means 
 SEM from 13 replicates. (F) ATP and GTP levels in M. smegmatis strains grown in the absence or
presence of ATc for 6 h to an OD	600 of0.6 in LB liquid media were measured by LC-MS/MS. The ratio of levels in the Tet-RelMtb
H80A strain (H80A) to those
in the Tet-RelMtb
WT-expressing strain (control) under the same conditions is graphed. Data are the means 
 SEM from 4 to 6 replicates. (E and F) The
significance of differences was determined by calculating P values by Student’s t tests; one asterisk indicates significance with a P value of 0.05, and three
asterisks indicates a significance with a P value of0.005. (G) Log ratio of transcript levels in the presence of ATc compared to the absence of ATc, illustrating
the induction of relMtb
WT and relMtb
H80A transcripts within 6 h of ATc treatment in Tet-RelMtb
WT and Tet-RelMtb
H80A strains, respectively. Data are the means

SEM from 3 replicates.
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tandem mass spectrometry (LC-MS/MS), but because of the low
levels of (p)ppGpp in the samples, the measurements observed
were not confidently reproduced. However, the same LC-MS/MS
approach was used to monitor ATP and GTP levels in LB liquid
cultures of M. smegmatis Tet-RelMtb
WT and Tet-RelMtb
H80A in the
presence and absence of ATc (Fig. 5F). We found that following
induction of relMtb
H80A expression in M. smegmatis for 6 h, GTP
levels were significantly decreased compared to those of strains
expressing RelMtb
WT. Conversely, ATP levels during induction of
relMtb
H80A expression were actually higher than those of control
strains. The increased transcription of the relMtb
H80A gene within 6
h of ATc treatment in the M. smegmatis Tet-RelMtb
H80A strain was
confirmed by qRT-PCR (Fig. 5G). These data demonstrate that
inhibition of (p)ppGpp hydrolysis impacts not only (p)ppGpp
levels but also ATP and GTP levels within the bacteria.
Inhibition of RelMtb (p)ppGpp hydrolase activity is lethal for
acute and chronic M. tuberculosis infection in mice. We next
investigated whether inhibition of (p)ppGpp hydrolysis, while
keeping (p)ppGpp synthesis intact, would compromise M. tuber-
culosis pathogenesis. We tested this by infecting mice with either
the control M. tuberculosis strain that expresses relMtb from its
native locus or the Tet-RelMtb
H80A strain that allows for condi-
tional expression of the relMtb
H80A allele in the presence of doxy-
cycline. We then determined bacterial titers in the lungs and
spleens during both acute and chronic infection (Fig. 6). In the
absence of doxycycline, control and Tet-RelMtb
H80A M. tuberculo-
sis strains displayed similar kinetics and virulence in mice (Fig. 6A
and B). Since both strains express TetR from a plasmid that also
confers streptomycin resistance and contain a kanamycin resis-
tant cassette integrated into the attB site that, in the case of Tet-
RelMtb
H80A, carries the relMtb
H80A allele, we could monitor the re-
tention of the Tet-inducible system during infection. By plating
the lung and spleen homogenates on plates containing streptomy-
cin and kanamycin, we showed that the Tet-inducible system was
intact for at least 10 weeks postinfection in both strains in the
absence of doxycycline (Fig. 6C). It was surprising that the Tet-
RelMtb
H80A strain was able to maintain high titers during chronic
infection, since the levels of relMtb
H80A transcripts were a log lower
than those in the control strain (Fig. 5A), and we have shown that
the absence of relMtb expression leads to lower titers during
chronic infection (Fig. 2). This indicated that the low-level leaky
expression of the relMtb
H80A allele in the absence of doxycycline
was able to result in enough (p)ppGpp synthesis to phenocopy
WT M. tuberculosis instead of the relMtb strain (Fig. 2) but not
too much (p)ppGpp synthesis to confer toxicity in the absence of
a functional hydrolase. In order to confirm that the low levels of
relMtb
H80A transcription allowed for synthesis of (p)ppGpp in the
Tet-RelMtb
H80A strain in the absence of inducer, we analyzed the
ability of this strain to form biofilms, which is a phenotype we had
previously shown requires (p)ppGpp synthesis (Fig. 1B). In the
absence of ATc, when only low levels of relMtb
H80A transcription
are occurring, the Tet-RelMtb
H80A strain was able to form biofilms
similar to those observed in WT RelMtb-expressing strains, further
supporting that the low level of relMtb
H80A transcription in the
absence of inducer is enough to allow for adequate (p)ppGpp
synthesis to confer normal bacterial physiology (Fig. 6D).
Separate groups of mice were infected with either control or
Tet-RelMtb
H80A M. tuberculosis strains and administered doxycy-
cline starting on day 1 (acute infection) (Fig. 6E and F) or day 63
(chronic infection) (Fig. 6G to I) postinfection to determine the
effect of inhibiting RelMtb (p)ppGpp hydrolase activity during
acute and chronic infection in mice. After 1 week of inducing
RelMtb
H80A expression with doxycycline at day 1 postinfection in
Tet-RelMtb
H80A, the bacteria were unable to replicate and de-
creased in titers to the point that 5 out of 6 animals tested had no
detectable M. tuberculosis in the lungs, with a limit of detection of
20 CFU. Additionally, none of the surviving Tet-RelMtb
H80A cells
at day 21 retained the Tet-inducible expression system, as deter-
mined by the lack of colony growth from lung homogenates on
plates containing streptomycin and kanamycin (Fig. 6F). In con-
trast, the control strain that expressed the endogenous relMtb allele
was not affected by doxycycline treatment at this stage of infection
(Fig. 6E) and retained the Tet-inducible expression system (Fig.
6F). These data demonstrate that even though M. tuberculosis was
capable of growth on 7H10 media during inhibition of RelMtb
(p)ppGpp hydrolase activity (Fig. 5B), this catalytic activity is es-
sential for acute infection in mice.
During chronic infection, expression of RelMtb
H80A caused a
2-log decrease of titers in the lungs (Fig. 6G) and a 1-log decrease
in the spleens (Fig. 6H) over a 4-week period. In the 4 weeks
following induction of RelMtb
H80A expression during chronic in-
fection, 93% of the Tet-RelMtb
H80A bacteria lost the plasmids en-
coding the Tet-inducible system and most likely reverted to relMtb
null by losing the allele and linked kanamycin resistant cassette at
the attB site (Fig. 6I). This would explain why the bacterial titers
did not recover after loss of the Tet-inducible system, since an M.
tuberculosis relMtb strain is attenuated for chronic infection (Fig.
2 and 6G and H). These data demonstrate that inhibition of the
RelMtb (p)ppGpp hydrolase activity in both acute and chronic
infection compromises M. tuberculosis survival and presents the
RelMtb hydrolase domain as a promising drug target. In addition,
suppression of the toxic effect of inhibiting the RelMtb (p)ppGpp
hydrolase activity by losing RelMtb-mediated (p)ppGpp synthetase
activity still leaves the bacteria unable to persist in the mouse
model of infection.
DISCUSSION
A previous study reported that an M. tuberculosis relMtb mutant
is attenuated for chronic infection in mice (14). In the same study,
microarray analyses revealed that more than a quarter of the ge-
nome was differentially expressed in the relMtb strain in both
nutrient-rich and depleted conditions, suggesting that there are
extensive metabolic alterations in strains lacking relMtb. The tran-
scripts affected included virulence factors, cell wall biosynthetic
enzymes, heat shock proteins, and secreted antigens, any of which
may contribute to the attenuation in vivo (14). In addition, WTM.
tuberculosis, but not therelMtb mutant, downregulated the cellu-
lar translation machinery during nutrient starvation, which is
consistent with RelMtb’s role in the stringent response and may
also be necessary for M. tuberculosis virulence (14).
RelMtb is a large protein encoding two distinct catalytic activi-
ties. Despite its importance for pathogenesis, it was still unknown
what function(s) of RelMtb contribute to its role in vivo. We have
dissected the roles of the two enzymatic activities encoded by
RelMtb during both growth in culture and pathogenesis in mice. By
studying a point mutant that specifically abolishes (p)ppGpp syn-
thesis by RelMtb, we conclude that (p)ppGpp production by RelMtb
is required for efficient rates of growth and biofilm formation in
culture, as well as for maintaining titers during chronic infection
in the mouse model of infection. It is worth noting that we do not
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have an antibody specific for RelMtb; therefore, we cannot confirm
that the RelMtb
H344Y protein is stably expressed and that the phe-
notypes are not due to decreased RelMtb protein rather than loss of
synthetase activity. However, there are multiple lines of evidence
that support that it is the loss of synthetase activity, and not pro-
tein instability, that results in these phenotypes. First, our group
and others are able to purify the mutant protein easily, and it is
stable in vitrowith no loss in hydrolase activity, suggesting that the
protein can fold normally and other domains can function in the
presence of the H344Y substitution (9 and data not shown). Sec-
ond, data presented here indicate that lower levels of RelMtb would
not phenocopy complete loss of the relMtb allele. For instance,
infection of mice with the Tet-RelMtb
H80A strain in the absence of
doxycycline, where relMtb






























































































































































































































FIG6 RelMtb (p)ppGpp hydrolase activity is essential for acute and chronicM. tuberculosis infection of mice. Bacterial titers in the lungs (A, E, and G) and spleens
(B and H) of C57BL/6 mice infected with either control or Tet-RelMtb
H80A (designated H80A in the figure)M. tuberculosis strains. The parent strain for the control
is WT M. tuberculosis Erdman, and the parent strain for Tet-RelMtb
H80A is M. tuberculosis relMtb. Both strains express TetR from a plasmid that confers
streptomycin resistance and contain a kanamycin resistance cassette integrated into the attB site that, in the case of Tet-RelMtb
H80A, carries the relMtb
H80A allele.
The strain symbols in panel A are the same for all panels. (A to C) Mice were given normal mouse chow throughout infection. (E and F) Mice were administered
doxycycline-containing mouse chow starting at day 1 postinfection (designated by the arrow). (G to I) Mice were administered doxycycline-containing mouse
chow starting at day 63 postinfection (designated by the arrow). (C, F, and I) The ratio of CFU from the lungs or spleens grown on 7H10 plates containing
streptomycin and kanamycin compared to 7H10 containing no antibiotics (No AB). ND denotes when no colonies were recovered after plating 5% of the lung
homogenate (limit of detection, 20 CFU). Data are means
 SEM of 6 Tet-RelMtb
H80A strain-infected mice and 3 control strain-infected mice per time point from
two replicate experiments. (E, G, and H) The significance of differences were determined by calculating P values by Student’s t tests; two asterisks indicate
significance with a P value of0.01, and three asterisks indicate significance with a P value of0.005. (D) M. tuberculosis Tet-RelMtb
H80A, relMtb, and relMtb
complemented with WT relMtb were normalized to the same OD	600 and grown in Sauton’s media under static, biofilm-forming conditions in a 24-well dish.
Biofilms were incubated for 4 weeks at 37°C.
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transcripts from the allele in WT M. tuberculosis (Fig. 5A),
indicated that even this low level of synthetase-active RelMtb
expression is able to sustain WT titers during chronic infection
of mice, unlike the relMtb- and RelMtb
H344Y-expressing strains
(Fig. 2 and 6).
(p)ppGpp has been shown to directly impact many processes
in other bacteria, including transcription of the translation ma-
chinery (26–29), GTP and ATP levels (30–33), DNA replication
(34–37), and metabolism (38–40). In general, the many effects of
(p)ppGpp are complex and seem to vary greatly among different
organisms. Any number of these mechanisms may be conserved in
mycobacteria, and determining which functions of (p)ppGpp
make its production necessary for chronic M. tuberculosis infec-
tion requires further study. Since it has been shown that (p)ppGpp
accumulates in mycobacteria during starvation (7, 23, 25), oxida-
tive stress (23), and stationary phase (7), these would be good
conditions to begin to investigate a molecular mechanism for
(p)ppGpp in M. tuberculosis.
Our experiments also demonstrate that the production of
(p)ppGpp is not the only role of RelMtb during pathogenesis. By
expressing a relMtb point mutant that retains the ability to synthe-
size (p)ppGpp but is unable to hydrolyze (p)ppGpp, our experi-
ments have highlighted a critical role for RelMtb-mediated hydro-
lysis of (p)ppGpp in colony morphology, survival, and virulence.
In contrast to (p)ppGpp synthesis, which is necessary for chronic
but not acute infection, hydrolysis of (p)ppGpp is required for all
stages ofM. tuberculosis infection in mice, suggesting a role for this
catalytic activity in general homeostasis. We predict that expres-
sion of the RelMtb
H80A hydrolase mutant leads to increased abun-
dance of (p)ppGpp, which may directly impact cellular pathways
in an uncontrolled manner that is detrimental for the bacteria. In
addition, we identify a dysregulation of ATP and GTP levels dur-
ing relMtb
H80A expression, which also may contribute to the lethal-
ity of expressing this allele. A recently published study on B. sub-
tilis highlighted a role for (p)ppGpp in directly inhibiting GTP
biosynthesis to maintain GTP levels within a range that supports
viability (33). To investigate whether the phenotypes caused by
relMtb
H80A expression in M. tuberculosis are due to the low levels of
GTP, we attempted to increase GTP production by adding
guanosine to the media, as was previously done in B. subtilis (33).
Unfortunately, guanosine supplementation did not restore WT
GTP levels, colony morphology, or growth rate during RelMtb
H80A
expression in mycobacteria. However, this may be due to inability
of the nucleoside to access the mycobacterial cytosol.
Evidence of the importance of controlling (p)ppGpp levels
specifically by hydrolysis activity comes from studies of small alar-
mone synthetase (SAS) homologs in B. subtilis (17, 18), Strepto-
myces mutans (19), Enterococcus faecalis (20), and Vibrio cholerae
(21). SAS proteins encode the catalytic domain to produce
(p)ppGpp but not the domain to hydrolyze it. Expression of a V.
cholerae or S. mutans SAS homolog in E. coli is toxic in the absence
of SpoT-mediated (p)ppGpp hydrolysis (19, 21), supporting the
theory that production of (p)ppGpp in the absence of a functional
hydrolase is deleterious. In addition, deletion of the respective SAS
homologs largely abolishes the slow-growth phenotypes of relA
strains of S. mutans, E. faecalis, and B. subtilis (17–20), which, like
M. tuberculosis relMtb, lack the only known enzyme capable of
hydrolyzing (p)ppGpp. These data suggest that in S. mutans, E.
faecalis, and B. subtilis, the slow growth of therelA mutant is due
to the lack of (p)ppGpp hydrolase activity in the presence of
(p)ppGpp synthesis.
With these data in mind, we have also reported the first inves-
tigations into the M. tuberculosis SAS homolog, rv1366. Interest-
ingly, another important finding from our experiments is that a
rv1366 strain exhibited WT rates of growth in liquid shaking
cultures, on plates, and in biofilms as well as WT levels of virulence
in the mouse model of infection. This indicates that under the
conditions we tested and during pathogenesis in the mouse
model, RelMtb is the main producer of (p)ppGpp. Deletion of
rv1366 had no effect on the phenotypes of therelMtb strain, dem-
onstrating that, unlike in other bacteria, the presence of an intact
M. tuberculosis SAS homolog allele was not a source of toxicity in
strains lacking RelMtb-mediated (p)ppGpp hydrolysis. Therefore,
the question regarding the role of Rv1366 in M. tuberculosis re-
mains unanswered. Murdeshwar et al. recently reported a study of
the M. smegmatis SAS homolog, which they term MS_RHII-RSD
because, unlike the M. tuberculosis homolog, MS_RHII-RSD en-
codes an amino-terminal RNase HII domain (41). The authors
show that a small amount of (p)ppGpp is produced in an M.
smegmatis relMsm mutant that is dependent on MS_RHII-RSD;
however, the importance of this activity for survival has not been
explored. Interestingly, the authors were unable to detect
(p)ppGpp synthetase activity in vitro using the region of
MS_RHII-RSD with homology to Rv1366, raising the possibility
that MS_RHII-RSD has evolved functions distinct from those of
Rv1366.
In summary, our data point toward a Goldilocks model of
(p)ppGpp levels in mycobacteria, where too little (p)ppGpp is
harmful for the bacteria in certain situations, like chronic infec-
tion, and too much is always deleterious. Recent antibiotic devel-
opment efforts aim to target RelMtb (p)ppGpp synthetase activity
as a therapeutic option (42, 43). We propose that tipping the bal-
ance of (p)ppGpp levels in the other direction by inhibiting
(p)ppGpp hydrolysis is also an attractive approach to targeting M.
tuberculosis. Our data imply that if we were to inhibit (p)ppGpp
hydrolysis with an antibiotic, mutants that develop resistance by
abolishing (p)ppGpp production would be unable to persist in the
host. Our findings would also apply to other bacteria that require
a balance of (p)ppGpp production.
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